Bava Roberto, Puteo Claudio, Lombardi Renato, Garcea Giuseppe, Lupia Carmine, Spano Angelica, Liguori Giovanna, Palma Ernesto, Britti Domenico, Castagna Fabio
Department of Health Sciences, University of Catanzaro Magna Græcia, 88054 Catanzaro, Italy.
Department of Clinical and Experimental Medicine, University of Foggia, 71121 Foggia, Italy.
Antibiotics (Basel). 2025 Feb 10;14(2):172. doi: 10.3390/antibiotics14020172.
Hive products, encompassing honey, propolis, bee venom, royal jelly, and pollen, are recognized for their antimicrobial and therapeutic properties. This review examines their chemical composition, explores their mechanisms of action, and discusses their potential applications in both human and veterinary medicine, particularly in addressing the challenge of antimicrobial resistance. This study utilized a comprehensive literature search strategy, gathering data from Google Scholar, MEDLINE PubMed, SciELO, and SCOPUS databases. Relevant search terms were employed to ensure a thorough retrieval of the pertinent literature. Honey, rich in bioactive compounds such as hydrogen peroxide and methylglyoxal, effectively disrupts biofilms and combats multi-drug-resistant pathogens, showing promise in treating a range of infections. Propolis, with its flavonoids and phenolic acids, demonstrates synergistic effects when used in conjunction with antibiotics. Bee venom, particularly its component melittin, exhibits antibacterial and immunomodulatory properties, although further research is needed to address toxicity concerns. Pollen and royal jelly demonstrate broad-spectrum antimicrobial activity, which is particularly relevant to animal health. Existing pre-clinical and clinical data support the therapeutic potential of these hive products. Hive products represent a vast and largely untapped natural resource for combating antimicrobial resistance and developing sustainable therapies, particularly in the field of veterinary medicine. However, challenges remain due to the inherent variability in their composition and the lack of standardized protocols for their preparation and application. Further research is essential to fully elucidate their mechanisms of action, optimize formulations for enhanced efficacy, and establish standardized protocols to ensure their safe and effective clinical use.
蜂产品,包括蜂蜜、蜂胶、蜂毒、蜂王浆和花粉,因其抗菌和治疗特性而闻名。本综述研究了它们的化学成分,探讨了它们的作用机制,并讨论了它们在人类和兽医学中的潜在应用,特别是在应对抗菌药物耐药性挑战方面。本研究采用了全面的文献检索策略,从谷歌学术、MEDLINE PubMed、SciELO和SCOPUS数据库收集数据。使用了相关的检索词,以确保全面检索相关文献。蜂蜜富含过氧化氢和甲基乙二醛等生物活性化合物,能有效破坏生物膜并对抗多重耐药病原体,在治疗一系列感染方面显示出前景。蜂胶及其黄酮类化合物和酚酸,与抗生素联合使用时显示出协同效应。蜂毒,特别是其成分蜂毒肽,具有抗菌和免疫调节特性,不过需要进一步研究以解决毒性问题。花粉和蜂王浆具有广谱抗菌活性,这对动物健康尤为重要。现有的临床前和临床数据支持这些蜂产品的治疗潜力。蜂产品是对抗抗菌药物耐药性和开发可持续疗法的巨大且在很大程度上未被开发的自然资源,特别是在兽医学领域。然而,由于其成分固有的可变性以及缺乏制备和应用的标准化方案,挑战依然存在。进一步的研究对于充分阐明其作用机制、优化配方以提高疗效以及建立标准化方案以确保其安全有效的临床使用至关重要。